Cargando…
Results of the ONTARGET and TRANSCEND studies: an update and discussion
The renin angiotensin aldosterone system (RAAS) plays an important role in the pathophysiology of cardiovascular disease. Angiotensin converting enzyme inhibitors (ACEi) have proven benefit in reducing cardiovascular events in patients at high risk. Angiotensin receptor blockers (ARB) have been demo...
Autor principal: | Fitchett, David |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672448/ https://www.ncbi.nlm.nih.gov/pubmed/19436659 |
Ejemplares similares
-
Clinical trial update: focus on the ONTARGET study
por: Fitchett, David
Publicado: (2007) -
A Gene Variant in CERS2 Is Associated with Rate of Increase in Albuminuria in Patients with Diabetes from ONTARGET and TRANSCEND
por: Shiffman, Dov, et al.
Publicado: (2014) -
Renal protection in diabetes: lessons from ONTARGET(®)
por: Ritz, Eberhard, et al.
Publicado: (2010) -
OnTarget: in silico design of MiniPromoters for targeted delivery of expression
por: Fornes, Oriol, et al.
Publicado: (2023) -
Transcending the self to transcend suffering
por: Ge, Brian H., et al.
Publicado: (2023)